MedTrace Logo

Cervical SNAG Half Rotation Technique in Cervicogenic Headache Patients.

NCT04788160 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2021-09-20

No results posted yet for this study

Summary

The purpose of this study is to find out the effect of cervical sustained natural apophyseal glide half rotation technique in patients with cervicogenic headache. Not many researches have focused specifically on the cervical sustained natural apophyseal glide half rotation technique and this study intends to see its effect in the cervicogenic headache patients.

Conditions

  • Cervicogenic Headache

Interventions

OTHER

Cervical SNAGs along with conventional therapy

cervical SNAG half rotation technique will be performed with the patient sitting on a chair in the erect posture. The therapist placed his thumb over thumb over the transverse process of C1. Then, he glided ventrally with active rotation of the restricted site 10 times holding for 10 seconds with overpressure at end of the rotation with 30 second rest in between each repetition and 3 session/week for 4 weeks. * Conventional therapy will include: * Hot pack over the cervical region for 10 minutes. * TENS for 10 minutes. * Furthermore, general stretching the upper cervical muscles will be done with 5 repetitions with 3 sessions/week for 4 weeks. * Isometric cervical extensor exercise with 10 seconds hold for 10 times will be done. * Cervical flexor strengthening will be done 10 times in sitting position.

OTHER

Conventional Therapy

* Patients in this group will undergo only conventional therapy which will include: * Hot pack for 15 minutes. * TENS for 10 minutes. * Furthermore, general stretching the upper cervical muscles will be done with 5 repetitions each 3 sessions/week for 4 weeks. * Isometric cervical extensor exercise with 10 seconds hold for 10 times will be done. * Cervical flexor strengthening will be given to the patient by the therapist, 10 times in sitting position.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Shafaq Shahid, MSPT(OMPT) · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-13
Primary Completion
2021-03-20
Completion
2021-03-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04788160 on ClinicalTrials.gov